Evidence map›Paper›PMID 27978540›Full record

ArticlePloS one2016

Exaggerations and Caveats in Press Releases and Health-Related Science News.

Petroc Sumner, Solveiga Vivian-Griffiths, Jacky Boivin, Andrew Williams, Lewis Bott, Rachel Adams, Christos A Venetis, Leanne Whelan, Bethan Hughes, Christopher D Chambers

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Caught in the Web of Words: Do LLMs Fall for Spin in Medical Literature?Proceedings of machine learning research · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Irish Media Coverage of COVID-19 Evidence-Based Research Reports From One National Agency.International journal of health policy and management · 2022
    Article
  19. Article
  20. Resveratrol and Wine: An Overview of Thirty Years in the Digital News.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Petroc SumnerCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.
Solveiga Vivian-GriffithsCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0001-5716-6202
Jacky BoivinSchool of Psychology, Cardiff University, Cardiff, United Kingdom.
Andrew WilliamsSchool of Journalism, Media & Cultural Studies, Cardiff University, Cardiff, United Kingdom.ORCID http://orcid.org/0000-0001-9603-4309
Lewis BottSchool of Psychology, Cardiff University, Cardiff, United Kingdom.
Rachel AdamsSchool of Psychology, Cardiff University, Cardiff, United Kingdom.
Christos A VenetisSchool of Women's and Children's Health, University of New South Wales (UNSW), Kensington, New South Wales, Australia.ORCID http://orcid.org/0000-0001-9591-7222
Leanne WhelanSchool of Psychology, Cardiff University, Cardiff, United Kingdom.
Bethan HughesSchool of Psychology, Cardiff University, Cardiff, United Kingdom.
Christopher D ChambersCardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundExaggerated or simplistic news is often blamed for adversely influencing public health. However, recent findings suggested many exaggerations were already present in university press releases, which scientists approve. Surprisingly, these exaggerations were not associated with more news coverage. Here we test whether these two controversial results also arise in press releases from prominent science and medical journals. We then investigate the influence of mitigating caveats in press releases, to test assumptions that caveats harm news interest or are ignored. METHODS AND

findingsUsing quantitative content analysis, we analyzed press releases (N = 534) on biomedical and health-related science issued by leading peer-reviewed journals. We similarly analysed the associated peer-reviewed papers (N = 534) and news stories (N = 582). Main outcome measures were advice to readers and causal statements drawn from correlational research. Exaggerations in press releases predicted exaggerations in news (odds ratios 2.4 and 10.9, 95% CIs 1.3 to 4.5 and 3.9 to 30.1) but were not associated with increased news coverage, consistent with previous findings. Combining datasets from universities and journals (996 press releases, 1250 news), we found that when caveats appeared in press releases there was no reduction in journalistic uptake, but there was a clear increase in caveats in news (odds ratios 9.6 and 9.5 for caveats for advice and causal claims, CIs 4.1 to 24.3 and 6.0 to 15.2). The main study limitation is its retrospective correlational nature.

conclusionsFor health and science news directly inspired by press releases, the main source of both exaggerations and caveats appears to be the press release itself. However we find no evidence that exaggerations increase, or caveats decrease, the likelihood of news coverage. These findings should be encouraging for press officers and scientists who wish to minimise exaggeration and include caveats in their press releases.

Indexed as

Mass MediaMedical WritingPublishingDeceptionHumansInformation DisseminationPublic Health

Identifiers

PMID27978540
PMCPMC5158314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.